Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Role of Toll-Like Receptors in the Pathogenesis of Covid-19 Publisher Pubmed



Khanmohammadi S1, 2 ; Rezaei N1, 2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  3. 3. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Medical Virology Published:2021


Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a pandemic since March 2020. The exact pathogenesis of SARS-CoV-2 and the role of each component of the innate and adaptive immune system is still unknown. However, available data from other coronavirus families, such as SARS-CoV and the Middle East respiratory syndrome and also new findings could be useful for a better understanding of SARS-CoV-2. Toll-like receptors (TLR) play an important role in recognition of viral particles and activation of the innate immune system. Activation of TLR pathways leads to secretion of pro-inflammatory cytokines, such as interleukin-1 (IL-1), IL-6, and tumor necrosis factor-α, as well as type 1 interferon. Different TLRs, like TLR2, TLR3, TLR4, TLR6, TLR7, TLR8, and TLR9 are potentially important in COVID-19 infection. It is also worth mentioning that we should bear in mind both the beneficial and harmful effects of TLR in confronting COVID-19 infection. TLRs could be a potential target in controlling the infection in the early stages of disease and production of vaccine against SARS-CoV-2. © 2021 Wiley Periodicals LLC
Other Related Docs
9. Immunotherapy for Sars-Cov-2: Potential Opportunities, Expert Opinion on Biological Therapy (2020)
10. Neurologic Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
12. Covid-19 in Patients With Cancer: Risks and Precautions, American Journal of Emergency Medicine (2021)
13. Coronavirus: Pure Infectious Disease or Genetic Predisposition, Advances in Experimental Medicine and Biology (2021)
15. Microfluidic Devices for Detection of Rna Viruses, Reviews in Medical Virology (2021)
18. Health and Art (Heart): Integrating Science and Art to Fight Covid-19, Advances in Experimental Medicine and Biology (2021)
19. The Epidemiologic Aspects of Covid-19 Outbreak: Spreading Beyond Expectations, Advances in Experimental Medicine and Biology (2021)
25. Covid-19 in Patients With Cancer, Advances in Experimental Medicine and Biology (2021)
26. Clinical Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
28. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
29. Covid-19 and Its Global Economic Impact, Advances in Experimental Medicine and Biology (2021)
32. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
35. Nutrition and Immunity in Covid-19, Advances in Experimental Medicine and Biology (2021)
39. Interdisciplinary Approaches to Covid-19, Advances in Experimental Medicine and Biology (2021)
41. Potential Antiviral Immune Response Against Covid-19: Lessons Learned From Sars-Cov, Advances in Experimental Medicine and Biology (2021)
43. Host Factors: Implications in Immunopathogenesis of Covid-19, Pathology Research and Practice (2021)
44. Anti-Ige Monoclonal Antibodies As Potential Treatment in Covid-19, Immunopharmacology and Immunotoxicology (2021)
46. Cytokines and Covid-19: Friends or Foes?, Human Vaccines and Immunotherapeutics (2020)
48. The Role of Type I Interferon in the Treatment of Covid-19, Journal of Medical Virology (2022)